Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02181764
What this trial is testing

KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia

Who this might be right for
X-linked Hypophosphatemic Rickets/Osteomalacia
Kyowa Kirin Co., Ltd. 15
Early research (Phase 1)Ended earlyNCT05839600
What this trial is testing

Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer

Who this might be right for
Solid Tumors
Boehringer Ingelheim 10
Testing effectiveness (Phase 2)Looking for participantsNCT06598007
What this trial is testing

Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultColorectal CancerPancreatic Ductal Adenocarcinoma
Crossignal Therapeutics, Inc. 78
Early research (Phase 1)WithdrawnNCT01593072
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc.
Early research (Phase 1)Study completedNCT02098967
What this trial is testing

The Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.

Who this might be right for
Neoplasms, Myelogenous Leukemia, Acute
Hoffmann-La Roche 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714395
What this trial is testing

Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Actuate Therapeutics Inc. 100
Early research (Phase 1)Study completedNCT01664000
What this trial is testing

A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Cellceutix Corporation 48
Early research (Phase 1)Study completedNCT00000812
What this trial is testing

A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Ended earlyNCT02848911
What this trial is testing

Safety Study to Assess AFM11 in Patients With Relapsed or Refractory Adult B-precursor ALL

Who this might be right for
Leukemia, B-Cell
Affimed GmbH 17
Early research (Phase 1)Study completedNCT06237777
What this trial is testing

A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients

Who this might be right for
Diabetic Macular Edema
Wang Min 3
Early research (Phase 1)Active Not RecruitingNCT06136819
What this trial is testing

RT-310 Dose Escalation BPH Study

Who this might be right for
BPH (Benign Prostatic Hyperplasia)Lower Urinary Tract Symptoms
Resurge Therapeutics Inc. 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03992430
What this trial is testing

Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)

Who this might be right for
Muscular Dystrophy, Duchenne
Sarepta Therapeutics, Inc. 160
Early research (Phase 1)Study completedNCT01554800
What this trial is testing

Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseAtherosclerosis
MedImmune LLC 16
Early research (Phase 1)Study completedNCT02325037
What this trial is testing

First-in-Human Single and Multiple Dose of GLPG1837

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 64
Early research (Phase 1)Study completedNCT01023230
What this trial is testing

Assess DV-601 in Subjects With Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Dynavax Technologies Corporation 14
Early research (Phase 1)Looking for participantsNCT06410131
What this trial is testing

Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16

Who this might be right for
Solid Tumors
Sound Biopharmaceuticals Ltd. 68
Early research (Phase 1)Study completedNCT00871910
What this trial is testing

Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)

Who this might be right for
Solid TumorsLymphoma, Non-HodgkinMultiple Myeloma
Merck Sharp & Dohme LLC 81
Early research (Phase 1)Looking for participantsNCT06804824
What this trial is testing

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Vividion Therapeutics, Inc. 220
Early research (Phase 1)Ended earlyNCT03182673
What this trial is testing

The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Jiangsu HengRui Medicine Co., Ltd. 31
Early research (Phase 1)Ended earlyNCT02083666
What this trial is testing

Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration

Who this might be right for
Healthy
Swedish Orphan Biovitrum 24
Next Page